Journal of Tea Science ›› 2009, Vol. 29 ›› Issue (3): 173-190.doi: 10.13305/j.cnki.jts.2009.3.001
CHEN Zong-mao
Received:
2009-03-23
Revised:
2009-04-10
Online:
2009-06-15
Published:
2019-09-06
CLC Number:
CHEN Zong-mao. Twenty Years Period in the Investigation on the Anticarcinogenic Activity of Tea[J]. Journal of Tea Science, 2009, 29(3): 173-190.
[1] H Fujiki, et al. Cancer inhibition by green tea[J], Mutation Res., 1998, 402:307~310. [2] H Fujiki.Green tea: Health benefits as cancer preventive for humans[J], The Chemical Record, 2005, 5:119~132. [3] NT Zaveri.Green tea and its polyphenolic catechins: Medicinial uses in cancer and noncancer applications[J]. Life Science, 2006,78: 2073~2080 [4] ZHEN Yongsu, CHEN zongmao, CHENG Shujing, et al.Tea: Bioactivity and therapeutic potential[C], Pp267, Taylor & Francis,2002. [5] A W Wu & M C Yu. Tea, hormone-related cancers and endogenous hormone levels[J], Mol. Nutr.Food Res., 2006, 50:160~169. [6] K Nakachi, Eguchi H & Imai K., Can teatime increase one’s lifetime?[J], Ageing Res Rev, 2003, 2: 1~10. [7] Katiyar SK & Mukhtar H. Tea in chemoprevention of cancer. Epidemiological and experimental study[J], Internat. J of Oncology, 1996, 8:221~238. [8] CS Yang, et al. Possible mechanisms of the cancer-preventive activities of green tea[J], Mol.Nutr. Food Res., 2006, 50:170~175 [9] Bushman J L.Green tea and cancer in humans: a review of the literature[J], Nutr. Cancer, 1998, 31:151~159. [10] Kohlmeier L, et al. Tea and cancer prevention: an evaluation of the epidemiologic literature[J], Nutr. Cancer, 1997,27:1~13. [11] Higdon JV & Frei B. Tea catechins and polyphenols:health effects, metabolism and antioxidant functions[J]. Critical Rev. in Fd & Nutr., 2003, 43:89~143. [12] CS Yang, Lambert JD, Ju J, et al.Tea and cancer prevention: Molecular mechanisms and human ewlevance[J], Tocicol. & Appl. Pharmacol., 2007, 224:265~273. [13] Osanai, et al. Enantioselective synthesis and proteasome inhibition of A-ring analogs of (-)-EGCG,the active ingredient of green tea extract[J], Heterocycles, 2008, 76:485~505. [14] J Landau, et al. Cancer prevention by tea and tea constituents[A], in “Carcinogenic and anticarcinogenic Food Components”[C], Ed.by Wanda baer-Dubowska, CRC Taylor & Francis, pp.219~237,2005.15 [15] AH Wu & MC Yu. Tea hormone-related cancers and endogenous hormone levels[J], Mol.Nutr. Food res.,2006, 50: 160~169 [16] J Clark & M You. Chemoprevention of lung cancer by tea[J], Mol. Nutr. Food Res.,2006, 50: 144~151 [17] Mantena SK, et al. Orally administration green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors[J]., J Nutr., 2005, 135:2871~2877. [18] Jankun J, Selman SH, Swiercz R, et al.Why drinking green tea could prevent cancer[J], Nature, 1997, 387: 561. [19] Hye-Kyung Na & Young-Joon Surh. Intracellular signaling network as a prime chemopreventive target of (-)epigallocatechin gallate[J]. Mol. Nutr. Food Res., 2006, 50:152~159. [20] Gupta S, et al. Molecular pathway for (-)EGCG-induced cell cycle arrest and apoptosis of human prostate carcinoma cells[J], Arch. Biochem. Biophys.,2003, 410:177~185. [21] S. Shankar, et al. Green tea polyphenols: biology and therapeutic implications in cancer[J], Frontiers in bioscience, 2007, 12:4881~4899. [22] D G Nagle, et al. Epigallocatechin-3-gallate(EGCG): Chemical and biomedical perspectives[J], Phytochemistry, 2006, 67:1849~1855. [23] Suganuma M,Okabe S, Kai Y, et al.Synergistic effects of (-)epigallocatechin gallate with sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9[J], Cancer Res., 1999, 59:44~47. [24] RA Hiipakkaet al.Structure-activity relationship for inhibition of human 5 α-reductase by poluphenols[J], Biochem. Pharmacol.,2002,63:1165~1176. [25] Weisburg JH, et al. In vitro cytotoxicity of EGCG and tea extracts to cancerous and normal cells from the human oral cavity[J], Basic Clin Pharmacol. Toxicol., 1997, 95:191~200. [26] 陈宗懋. 茶多酚类化合物抗癌的生物化学和分子生物学基础[J]. 茶叶科学, 2003, 23(2): 83~93. [27] JH Weisburger & Fung-Lung Chung. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols[J], Fd & Chem. Toxocol., 2002, 40:1145~1154 [28] YC Liang, et al. Inhibition of cyclin-depedent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)epigallocatechin-3-gallate[J], Biochem. Biophys. Res. Commun., 1999, 275:328~334. [29] Sah, J F, et al. Epigallocatechin gallate inhibits epidermal growth factor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases[J], J. Biol. Chem., 2004, 279:12755~12762. [30] Zhao Y, et al. Induction of apoptosis by epigallocatechin gallate via mitochondrial signal transduction pathway[J], Prev. Med., 2001, 39:1172~1179.31 [31] S Ermakova, Choi BY, Choi HS, et al.The intermediate filament protein Vimentin is a new target for Epigallocatechin gallate[J], J. Biol. Chem., 2005, 280:16882~16890. [32] Adhami V M, Ahmad N, Mukhtar H.Molecular targets for green tea in prostste cancer prevention[J], J Nutr, 2003, 133:2417S~2424S. [33] Puig, et al. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate(EGCG)and C75[J], Breast Cancer Res. Treat, 2007 (on line) [34] Van der Hof KH, et al. Consumption of green or black tea does not increase resistance of low density lipoprotein to oxidation in humans[J], Am. J Clin. Nutr.,1997, 66: 1125~1132 [35] Susan B, et al. Green tea polyphenols and cancer chemoprevention: Multiple mechanisms and endpoints for phase II trials[J], Nutrition Reviews,2004, 62:204~211. [36] Yim DS, et al. Relationship between the Val158Met polymorphism of catechol-0-methyl transferase and breast cancer[J], Pharmacogenetics, 2001, 11:279~286. [37] Wu AH, et al. Tea intake, COMT genotype, and breast cancer in Asian-American women[J], Cancer Res. ,2003, 63:7526~7529. [38] T Sugiyama & Y Sadzuka. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents[J], Biochim. Biophys. Acta, 2003, 1653;47~59. [39] JD Lambert & CS Yang. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols[J], Mutation Res., 2003, 523-524:201~208. [40] Qin L, et al. A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the P13K/Akt pathway and Bcl-2 family proteins[J], Biochem. Biophy. Res. Commun., 2007, 354:852~857. [41] U Bachrach & YC Wang. Cancer therapy and prevention by green tea: role of ornithine decarboxylase[J], Amino Acids, 2002, 22:1~13 [42] F Tosetti, et al. Angioprevention:angiogenesis is a common and key target for cancer chrmopreventive agents[J], FASEB J.,2002, 16:2~14. [43] S Garbisa, et al. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate[J], Cancer, 2001, 91:822~832 [44] Naasanil S, et al. Telomerase inhibition, telomere shortening and senescense of cancer cells by tea catechins[J],Biochem Biophys. Res., Commun., 1998, 249; 391~396. [45] Sohn OS, Surace A, Fiala ES, et al.Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male rat[J], Xenobiotica 1994,24:119~127. [46] Silverman N, et al. NF-KappaB signaling pathways in mammalian and insect innate immunity[J], Genes Dev., 2001, 15:2321~2342. [47] E Navarro-Peran, et al. The antifolate activity of tea catechins[J], Cancer Res., 2005, 65(6): 2059~2064. [48] Harland B.Caffeine and nutrition[J],Nutrition,2000, 16:522~526. [49] N Ahmad, et al. Nitric oxide synthase and skin tumor promotion[J], Biochem. Biophy. Res. Commun., 1997, 232:328~331. [50] Sartor Let al., (-)EGCG inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema and invasion[J], J Leuk.Biol., 2002, 71:71~79. [51] Lin YL, et al. EGCG blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nucluear factor-K B[J] Molec. Pharmacol., 1997,52:465~472. [52] Dong Z, et al. Inhiition of tumor-induced activator protein 1 activation and cell transformation by tea polyphenols[J], Cancer Res.1997, ,57:4414~4419. [53] Zhao Y, et al. Induction of apoptosis by epigallocatechin- 3-gallate via mitochondrial signal transduction pathway[J]., Prev. Med., 2004, 39:1172~1179. [54] RA Isbrucker, et al. Safety studies on epigallocatechin gallate (EGCG) preparation, Part I. Genotoxicity Food & Chem Toxicol, 2005, 44: 631~635. [55] R A Isbrucker, et al. Safety Studies on Epigallocatechin gallate (EGCG) preparations.Part 2.:Dermal, acute and short-term oxicity studies[J], Food & Chem. Toxicol.,2005, 44:636~650 [56] R A Isbrucker, et al. Safety Studies on Epigallocatechin gallate (EGCG) preparations.Part 3: Teratogenicity and reproductive toxicity studies in rats[J], Food & Chem. Toxicol., 2005,44:651~657. [57] Nijveldt R, et al. Flavonoids: a review of probable mechanisms of action and potrential applications[J], Am. J. Clin. Nutr., 2001, 74:418~425. [58] D S Barbosa.Green tea polyphenolic compounds and human health[J], J. Verbr. Lebensm., 2007, 2:407~413. [59] Hastak K, et al. Role of P53 and NF-kappaB in epigallocatechin gallate-induced apoptosis of LNCaP cell[J].,Oncogene, 2003 22:4851~4859. [60] Okabe S, Ochiai Y, Park K, et al. Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array[J], Biol. Pharmacol. Bull., 2001, 24:883~886. [61] Lee M J, Lambert JD, Prabhu S, et al. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract[J], Cancer Epidemio. Biomark. & Prevent., 2004, 13:132~137. [62] Nakaqchi K, Eguchi H, Imai K.Can tea time increase one’s lifetime?[J] Ageing Resear. Rev.,2003, 2:1~10 [63] Gupta S, et al. Growth inhibition, cell cycle dysesgulation and induction of apoptosis by green tea constituent EGCG in androgen-sensitive and androgen-insensitive human prostste carcinoma cells[J], Toxicol. Appl. Pharmacol, 2000, 164:82~90 [64] Zingarelli Bet al, Nuclear factor-kB as a therapeutic target in critical care medicine[J], Crit. Care Med., 31(suppl 1):2003, S 105~S 111. [65] Cao Y &, Cao R.Angiogenesis inhibited by drinking tea[J], Nature, 1999, 398:381 [66] Esteller M, et al. A gene hypermethylation profile of human cancer[J], Cancer Res., 2001, 61:3225~3229. [67] Ferrara N.Molecular and biological properties of vascular endothelial growth factors[J]. J Molecular Medicine, 1999,77:527~543 [68] A Kojima-Yuasa, et al. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors[J], Life Sci., 2003, 73:1299~1313 [69] Jung YD —LM Ellis, EGCG, a major component of green tea, inhibits tumor growth by inhibiting VEGF induction in human colon carcinoma cells[J]., Brit. J of Cancer, 2001, 84:844~850. [70] G Fassina, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate[J], Clin. Cancer Res, 2004, 10:4865~4873. [71] Mantena SK, et al. Epigallocatechin gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors[J]. Photochem. Photobiol., 2004, 81:1174~1179. [72] K Matsubara, et al. Epicatechin conjugated with fatty acid is a potent inhibitor of DNA polymerase and angiogenesis[J], Life Sci., 2007, 80:1578~1585. [73] W Y Feng.Metabolism of green tea catechins: An overview, Current Drug Metabolism[J], 2006, 7: 755~809. [74] Chow HH, Cai Y, Hakim, IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals[J], Clin. Cancer Res., 2003, 9:3312~3319. [75] L Chen, Lee MJ, Li H, et al. Absorption, distribution and elimination of tea polyphenols in rats[J], Drug Metabol. Disp.,1997, 9:1045~1050. [76] Lambert JD, Lee MJ, Lu H, et al. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice.[J], J N ut., 2003, 133:4172~4177. [77] Nakagawa K & Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin gallate, in the rat[J], J Nut. Sci. Vitaminol.,(Tokyo), 1997, 43: 679~684. [78] H, Chow, Cai Y, Albert DS, et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E[J]., Cancer Epidemiol. Biomarkers Prev., 2001, 10:53~58. [79] H-H S Chow, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals[J], Clin. Cancer Res., 2005, 11:4627~4733. [80] C Linpinski, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings[J]. Adv. Drug Deliv. Rev., 2001, 46:3~26. [81] C Yang, Chen L, Lee MJ, et al. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers[J]., Cancer Epidemiol. Biomarkers Prev., 1998, 7:351~354. [82] JG Hengstler, et al. Can drinking tea present cancrer?[J] Arch. Toxicol., 2008, 82:(published online:09 Dec. 2008) [83] Lee MJ, et al. Analysis of plasma and urinary tea polyphenols in human subjects[J], Cancer, Epidemiol. Biomarkers Prev., 1995, 4:393~399. [84] Lee MJ, Maliakal P, Chen L, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability[J]., Cancer Epidemiol. Biomarkers Prev., 2002, 11: 1025~1032. [85] Yang C S, Lee MJ, Chen L.Human salivary tea catechin levels and catechin esterase activities;implication in human cancer prevention studies[J], Cancer Epidemiol. Biom ark. Prev., 1999, 8:83~89. [86] Li L & Chan TH. Enantioselective synthesis of EGCG, the active polyphenol component from green tea[J], Org. Lett., 2001, 3:739~741 [87] J George, et al. Tea: age-old beverage as an effective cancer chemopreventive agent[J], Oncol Rev., 2008, 1:243~252. [88] Yang CS .Inhibition of carcinogenesis by tea[J], Nature, 1997, 389,134~135. [89] Wan SB, D Chen, QP Dou, et al. Study of the green tea polyphenols CG and ECG as proteasome inhibitors[J], Bioorg. Med Chem., 2004, 12:3521~3527. [90] Hou Cet al.The challenge of developing green tea polyphenols as therapeutic agents[J], Inflammopharmacology, 2008, 16:1~5. [91] N Khan & H Mukhtar Tea polyphenols for health promotion[J], Life Sci., 2007, 81:519~533. [92] JD Lambert, et al. possible controversy over dietary polyphenols: benefits vs risks[J], Chem. Res. Toxicol., 2007, 20:583~585. [93] KR Landis-Piwowar, C Huo, D Chen, et al. A novel prodrug of the green tea polyphenol (-)-Epigallocatechin-3-gallate as apotent anticancer agent[J], Cancer Res., 2007, 67:4303~4310. [94] SC Lee, WK Chan, TW Lee, et al. Effect of a prodrug of the green tea polyphenol (-)-Epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo[J], Nutr. & Cancer, 2008, 60;483~491. [95] QP Dou, KR Landis-Piwowar, D Chen, et al. Green tea polyphenols as a natural tumour cell proteasome inhibitor[J], Inflammopharm, 2008, 16:1~5 [96] C Huo, G Shi, WH Lam, et al. Semi-synthesis and proteasome inhibition of D-ring deoxy analogs of (-)-epigallocatechin gallate (EGCG), the active ingredient of green tea extract[J],Can. J Chem., 2008, 86: 495~502. [97] BT Utenova, KE Malterud & F Rise. Antioxidant activity of O-protected derivatives of (-)-epigallocatechin-3-gallate: inhibition of soybean and rabbit 15-lipoxygenases[J], ARKIVOC, 2007, 9:6~16. [98] Wan SB, KR Landis-Piwowar, DJ Kuhn, et al. Structure-activity study of EGCG analogs as proteasome inhibitors[J], Bioorg Med. Chem., 2005, 13:2177~2185. [99] Wan SB, et al. Regiospecific and enantioselective synthesis of methylaed metabolites of tea catechins[J], Tetrahedron, 2006,62:5897~5904. [100] Osanai, Huo KR, Landis-Piwowar, et al. A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer[J], Bioorganic & Medic. Chem., 2007, 15:5076~5082. [101] K Nakagawa, et al. Antioxidative activity of 3-O-Octanoyl-(+)-catechin, a newly synthesized catechin, in vitro.[J], J. Health Sci., 2005, 51:492~496. [102] N Katunuma, et al. Catechin derivatives: specific inhibitor for caspases-3,7 and 2, and the prevention of apoptosis at the cell and animallevels[J], FEBS Letters, 2006, 580:741~746. [103] Haslam E.Natural polyphenols (vegetable tannins) as drugs: possible modes of action.[J], J Nat. Prod., 1996, 59:205~215. [104] Ullmann U,Haller J, Decourt JP, et al. A single ascending dose study of epigallocatechin gallate in healthy volunteers[J]. J int. Med. Res., 2003,31:88~101. [105] Bettuzzi S, Brausi M, Rizzi, F, et al. Chemoprevention of human prostste cancer by oral administration of green tea catechins in volunmeers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study[J], Cancer Res., 2006, 66:1234~1240. [106] Kazi A, Wang Z, Kumar N, et al. Structure-activity relationships of synthetic analogs of (-)EGCG as proteasome inhibitors[J], Anticancer Res., 2004, 24:943~954. [107] Landis-Piwowar KR, Huo CD, Chen D, et al. Methyation suppresses the proteasome-inhibitory function of green tea polyphenols[J], J Cell Physiology, 2007, 213:252~260. [108] Lee SK, WK Chan, TW Lee, et al. Effect of a pro-drug of the green tea polyphenolEGCG on the growth of androgen independent prostate cancer in vitro[J], Nutri. Cancer,2008, 60:483~491. [109] Schilter Bet al., Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements[J], Food Chem. Toxicol., 2003, 41:1625~1649. [110] Yang CSet al.Antioxidative and anti-carcinogenic activities of tea polyphenols [J], Arch. Toxicol., 2008,82:(Accessed 12 Nov 2008). [111] K Matsubaraet alEpicatechin conjugated with fatty acid is a potent inhibitor of DNA polymerase and angiogenesis[J], Life Sci.,2007, 80:1578~1585. [112] Galati G, et al. Cellular and in vitro hepatoxicity caused by green tea phenolic acids and catechins[J], Free radical Biol Med, 2006, 40:570~580. [113] S Uesato, et al. Inhibitory effects of 3-O-Acyl-(+)-catechins on Epstein-Barr virus activation[J], Chem Pharm Bull, 2003, 51:1448~1 [114] S Azam, et al. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3- gallate: implications for anticancer properties[J]. Toxicology in vitro, 2006,18:555~561. [115] 杨贤强, 王岳飞, 陈留记, 等. 茶多酚的化学[C]. 上海: 上海科学技术出版社, 2003. [116] EC Stuart, et al. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostste cancer[J], Life Sci.,2006, 79:2329~2336. [117] YC Wang & U Achrach. The specific anti-cancer activity of green tea (-)-epigallocatechin -3-gallate, Amino Acids[J], 2002, 22:131~143 [118] X Wang & W Tian. Green tea Epigallocatechin gallate: A natural inhibitor of fatty-acid synthase[J], Biochem. Biophy. Res. Communic., 2001, 288:1200~1206 [119] JD Lambert, Sang S, Hong J, et al. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of EGCG[J], Drug Metabol. & Disp., 2006, 34:2111~2115. [120] Khan SG, et al. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention[J], Cancer Res., 1992, 52:4050~4052. [121] YJ Surh.NF-kB and AP-1 as molecular targets for chemoprevention with EGCG, a review[J], Environ Chem Lett., 2006, 4:137~141. [122] C S Hofmann & G E Sonenshei., green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle via activation of p53[J], FASEB J, 2003,17:702~704. |
[1] | YAN Duo, YU Penghui, GONG Yushun. Research Progress on the Impact of Environmental Stresses on Tea Quality during the Withering Process [J]. Journal of Tea Science, 2025, 45(1): 1-14. |
[2] | DONG Yuan, ZHANG Yongheng, XIAO Yezi, YU Youben. Cloning of BZR1 Gene Family in Tea Plants and Molecular Mechanism Study of CsBZR1-5 Response to Drought Stress [J]. Journal of Tea Science, 2025, 45(1): 15-28. |
[3] | MA Xueqing, WU Huawei, CAO Chunxia, ZHENG Jiaoli. Screening of Phosphate-solubilizing Bacteria in the Rhizosphere of Tea Gardens and Their Effects on Tea Yield, Quality and Soil Properties [J]. Journal of Tea Science, 2025, 45(1): 110-120. |
[4] | LIN Dongyi, HUANG Chong, WANG Weiming, HUANG Yan, FENG Xinkai. Research on Performance Optimization of Tea Residue Powder-Based Triboelectric Nanogenerator and It’s Application in Wind Monitoring System [J]. Journal of Tea Science, 2025, 45(1): 121-132. |
[5] | MA Mengjun, HU Xinlong, QIU Shouzhe, ZHANG Ruiming, TANG Huishan, LIU Chen, YU Ziming, LI Jing, WANG Mingle. Comparative Metabolome Analysis of the Main Chemical Compositions in Qingzhuan Tea with Different Storage Years [J]. Journal of Tea Science, 2025, 45(1): 133-144. |
[6] | XU Jinping, DU Xuemei, LÜ Wanyi, ZHU Lei, ZHANG Danyang, CHEN Hongping, CHEN Ling, CHAI Yunfeng. Leaching Behavior and Risk Assessment of Seven Different Polar Pesticides in Green Tea during Brewing [J]. Journal of Tea Science, 2025, 45(1): 157-168. |
[7] | YANG Nan, LI Zhuan, LIU Meichen, MA Junjie, SHI Yuntao, WEI Xiangning, LIN Yangshun, MAO Yuyuan, GAO Shuilian. Studies on the Regulation of EGCG Biosynthesis in Tea Plants by Potassium Nutrition [J]. Journal of Tea Science, 2024, 44(6): 887-900. |
[8] | ZHAO Qian, LIU Qian, CAI-HE Jiayi, HE Jieqi, FANG Yunya, LIU Yuxin, CHEN Chao, ZHENG Yaodong, ZHANG Tianjing, YU Wenjuan, YANG Guang. Effects of Combined Drought and Low-temperature Stress on Photosynthetic Physiological Characteristics of Tea Plants and Simulation Prediction [J]. Journal of Tea Science, 2024, 44(6): 901-916. |
[9] | LIU Xiaolu, ZHU Yalan, YU Min, GAI Xinyue, FAN Yangen, SUN Ping, HUANG Xiaoqin. Changes in Cell Wall Structure and Photosynthetic Characteristics of Tea Leaves under Low Temperature Stress [J]. Journal of Tea Science, 2024, 44(6): 917-927. |
[10] | ZHAO Jiancheng, NI Huijing, WANG Bo, CAI Chunju, YANG Zhenya. Effect of Bamboo Density on the Physiological Growth and Tea Quality of Tea Plants under the Moso Bamboo Forest [J]. Journal of Tea Science, 2024, 44(6): 928-940. |
[11] | YANG Xiaowei, SHEN Qiang, LUO Jinlong, ZHANG Tuo, YANG Ting, DAI Yuqiao, LIU Zhongying, LI Qin, WANG Jialun. Research on Tea Bud Recognition Based on Improved YOLOv8n [J]. Journal of Tea Science, 2024, 44(6): 949-959. |
[12] | ZHANG Shuyi, MA Chengying, CHEN Wei, MIAO Aiqing, QIAO Xiaoyan, LIN Dongchun, XIA Hongling, XU Jingyi. Optimization and Application of Analysis Method for Volatile Enantiomers in ‘Jinxuan’ Roasted Green Tea [J]. Journal of Tea Science, 2024, 44(6): 973-984. |
[13] | ZHOU Hongyu, WANG Yuanyuan, LI Faxin, NIE Congning, FENG Dejian, ZHAO Yueling, DU Xiao. Evaluation of Aroma Types and Key Aroma Components of Bud-leaf Type Yellow Tea Based on GC-O-MS [J]. Journal of Tea Science, 2024, 44(6): 985-1004. |
[14] | NIE Qing, PANG Yuelan, WU Huan, DING Shuqia, ZHONG Keyu, LIU Zhonghua, CAI Shuxian. Neuroprotective Mechanisms of Aged Liupao Tea against Aβ25-35-induced PC12 Cell Damage [J]. Journal of Tea Science, 2024, 44(6): 1005-1013. |
[15] | XU Wenqi. Determination of Selenium in Tea by Microwave Digestion-inductively Coupled Plasma Mass Spectrometry (ICP-MS) [J]. Journal of Tea Science, 2024, 44(6): 1014-1022. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|